Results 131 to 140 of about 3,528 (147)
New diagnosis of multiple sclerosis in the setting of recent Sinopharm COVID-19 vaccine (BBIBP-CorV) exposure: A series of clinical cases and updated review of the literature. [PDF]
Curr J NeurolPaybast S +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon [PDF]
Vaccine, 2021 Facing new COVID-19 waves, the effectiveness of BBIBP-CorV has been noted to be low in countries whose populations were already administered two doses of the vaccine.
Rima Moghnieh +2 more
exaly +2 more sources
Cell, 2020 The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens global public health. The development of a vaccine is urgently needed for the prevention and control of COVID-19.
Wei Deng +2 more
exaly +2 more sources